ArticleActa paediatrica (Oslo, Norway : 1992)2025
Unexplained gut symptoms in extremely preterm infants are associated with gastrointestinal dysfunction at 5.5 years.
Article in Acta paediatrica (Oslo, Norway : 1992), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unexplained gut symptoms in extremely preterm infants are associated with gastrointestinal dysfunction at 5.5 years.Acta paediatrica (Oslo, Norway : 1992) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
aimTo evaluate whether extremely preterm infants with considerable gastrointestinal (GI) symptoms during the neonatal period, but without major abdominal surgery or necrotising enterocolitis, had an increased probability of developing GI dysfunction later in life.
methodsA retrospective, case-control study on extremely preterm neonates that underwent an upper gastrointestinal contrast series (UGI) between 2012 and 2017, with UGI used as a marker of considerable GI symptoms. Controls were matched for sex and gestational age. The primary outcome was GI dysfunction requiring ongoing medical support at 5.5 years. Secondary outcomes included respiratory, neurological and growth abnormalities.
resultsThirty-three patients and 66 controls were included; mean gestational age at birth was 25w + 4d. Cases had an odds ratio of 3.8 (p = 0.005; 95% CI = 1.47-9.82) for developing GI dysfunction at 5.5 years after adjusting for confounders. Neonatal morbidities of sepsis, patent ductus arteriosus and hypothyroidism were more common in cases (p < 0.05). No differences were seen in secondary outcomes at 5.5 years of age.
conclusionExtremely preterm infants with unexplained GI symptoms during the neonatal period had increased odds of developing GI dysfunction later in life, which was not explained by other morbidities. We suggest appropriate attention concerning later GI dysfunction in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.